Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

On 4 Oct 2018, the MORU Malaria Dept, in collaboration with the Global Sepsis Alliance (GSA), hosted the inaugural meeting of a proposed Asian Sepsis Alliance in Bangkok.

Group photo of the Sepsis Alliance

The meeting drew intensive care and infectious disease physicians from 9 Asian-Pacific countries (Thailand, Pakistan, India, Sri Lanka, Bangladesh, Malaysia, Singapore, China and Australia). GSA heads Profs Konrad Reinhart, Simon Finfer and Flavia Machado also attended, as did Direk Limmathurotsakul, Prof Abul Faiz, Rashan Haniffa, Abi Beane and Arjen Dondorp from MORU.

An Asian branch of the GSA was founded at the meeting and an initial steering group was constituted. The group will advocate for better recognition and treatment of sepsis, an often underestimated frequent cause of death, and help coordinate obtaining regional epidemiological data on sepsis.

Similar stories

Simple new method that measures viral clearance means antibody treatments for COVID and ‘flu can be quickly assessed for effectiveness, say MORU researchers

Measuring the rate of viral clearance from the back of the mouth in patients with mild infections can be used to determine quickly and inexpensively if an antibody is effective in future COVID-19, influenza and other respiratory virus pandemics, say researchers in a letter published today in The Lancet.